Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof-of-Concept Clinical Research Study of Efavirenz in Patients With Alzheimer's Disease

NCT03706885 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.

NCT NCT03706885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03706885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof-of-Concept Clinical Research Study of Efavirenz in Patients With Alzheimer's Disease
Lead sponsor
Case Western Reserve University
Phase
Phase 1
Overall status
Completed
Start date
May 5, 2018
Completion date
January 28, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, early onset